These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11260880)

  • 1. [Suppressive effect of lansoprazole on anti-Candida activity of murine macrophages].
    Motegi H; Abe S; Tansho S; Suzuki D; Yamaguchi H; Hoshino E
    Kansenshogaku Zasshi; 2001 Feb; 75(2):137-43. PubMed ID: 11260880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor.
    Biswas SK; Yokoyama K; Kamei K; Nishimura K; Miyaji M
    Med Mycol; 2001 Jun; 39(3):283-5. PubMed ID: 11446532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gastric H,K-ATPase blocker lansoprazole is an inhibitor of chloride channels.
    Schmarda A; Dinkhauser P; Gschwentner M; Ritter M; Fürst J; Scandella E; Wöll E; Laich A; Rossmann H; Seidler U; Lang F; Paulmichl M
    Br J Pharmacol; 2000 Feb; 129(3):598-604. PubMed ID: 10711360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.
    Pauli-Magnus C; Rekersbrink S; Klotz U; Fromm MF
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):551-7. PubMed ID: 11770010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction.
    Masubuchi N; Hakusui H; Okazaki O
    Biochem Pharmacol; 1997 Dec; 54(11):1225-31. PubMed ID: 9416973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole.
    Andersson T; Holmberg J; Röhss K; Walan A
    Br J Clin Pharmacol; 1998 Apr; 45(4):369-75. PubMed ID: 9578184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial cell growth.
    Nakajima N; Kuwayama H; Iwasaki A; Arakawa Y
    J Clin Gastroenterol; 1995; 20 Suppl 2():S90-2. PubMed ID: 7594352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Li XQ; Andersson TB; Ahlström M; Weidolf L
    Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
    Tomiyama Y; Morii M; Takeguchi N
    Biochem Pharmacol; 1994 Nov; 48(11):2049-55. PubMed ID: 7802694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
    Sharma VK
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of lansoprazole against Helicobacter pylori.
    Figura N; Crabtree JE; Dattilo M
    J Antimicrob Chemother; 1997 May; 39(5):585-90. PubMed ID: 9184356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of C3H/HE J mice from development of Candida albicans infection by oral administration of Juzen-taiho-to and its component, Ginseng radix: possible roles of macrophages in the host defense mechanisms.
    Akagawa G; Abe S; Tansho S; Uchida K; Yamaguchi H
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):73-89. PubMed ID: 8683040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug of the month. Lansoprazole (DakaR)].
    Scheen AJ
    Rev Med Liege; 1995 Mar; 50(3):133-4. PubMed ID: 7724943
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective inhibition of Candida albicans growth by the combination of murine peritoneal neutrophils and activated macrophages.
    Tansho S; Abe S; Tansho T; Yamaguchi H
    Microbiol Immunol; 1999; 43(3):235-40. PubMed ID: 10338192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro.
    Midolo PD; Turnidge JD; Lambert JR
    J Antimicrob Chemother; 1997 Mar; 39(3):331-7. PubMed ID: 9096182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of acid secretion following treatment with proton pump inhibitors.
    Shin JM; Sachs G
    Gastroenterology; 2002 Nov; 123(5):1588-97. PubMed ID: 12404233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of anti-Candida activity of macrophages by a quorum-sensing molecule, farnesol, through induction of oxidative stress.
    Abe S; Tsunashima R; Iijima R; Yamada T; Maruyama N; Hisajima T; Abe Y; Oshima H; Yamazaki M
    Microbiol Immunol; 2009 Jun; 53(6):323-30. PubMed ID: 19493200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells.
    Ohara T; Arakawa T
    Dig Dis Sci; 1999 Aug; 44(8):1710-5. PubMed ID: 10492157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.